- Report
- April 2025
- 171 Pages
Global
From €4470EUR$4,900USD£3,844GBP
- Report
- October 2024
- 188 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP
- Report
- April 2025
- 158 Pages
Global
From €4972EUR$5,450USD£4,276GBP
- Report
- April 2025
- 193 Pages
Global
From €4516EUR$4,950USD£3,884GBP
- Report
- July 2023
- 111 Pages
Global
From €4105EUR$4,500USD£3,531GBP
Molecular Oncology Diagnostics is a type of diagnostic testing used to detect and monitor cancer. It involves the analysis of genetic material from a patient's tumor or other tissue sample to identify mutations that can be used to diagnose and classify cancer. Molecular Oncology Diagnostics can also be used to monitor the effectiveness of treatments and to detect recurrence of cancer. This type of testing is becoming increasingly important in the diagnosis and treatment of cancer, as it can provide more accurate and detailed information than traditional methods.
Molecular Oncology Diagnostics can be used to detect mutations in genes associated with cancer, such as those involved in cell growth and division, as well as those that control the body's immune response. It can also be used to detect changes in the expression of certain proteins, which can indicate the presence of cancer. In addition, Molecular Oncology Diagnostics can be used to detect changes in the structure of DNA, which can indicate the presence of cancer-causing mutations.
Companies in the Molecular Oncology Diagnostics market include Illumina, Thermo Fisher Scientific, Agilent Technologies, QIAGEN, and Roche. Show Less Read more